NO178504C - Fr.måte for fr.stilling av minaktivin,DNA-molekyl,gen,vert,prober,preparat som omfatter prober,reagens for lokalisering og defini. av grenser for tumor i histologiske pröver,samt anvendelse av DNA-molekyl,minaktivin og preparat - Google Patents

Fr.måte for fr.stilling av minaktivin,DNA-molekyl,gen,vert,prober,preparat som omfatter prober,reagens for lokalisering og defini. av grenser for tumor i histologiske pröver,samt anvendelse av DNA-molekyl,minaktivin og preparat

Info

Publication number: NO178504C
Authority: NO; Norway
Prior art keywords: minactivin; preparation; dna molecule; probes; well
Prior art date: 1986-03-13

Application number

NO874704A

Other languages

English (en)

Norwegian (no)

Other versions

NO178504B (no

NO874704L (no

NO874704D0 (no

Inventor

Toni Marie Antalis

Michael Thomas Barnes

Michelle Alison Clark

Peter Leonard Devine

Neil Howard Goss

Philip Ralph Lehrbach

Original Assignee

Biotech Australia Pty Ltd

Univ Australian

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-03-13

Filing date

1987-11-11

Publication date

1996-04-10

1987-11-11 Application filed by Biotech Australia Pty Ltd, Univ Australian filed Critical Biotech Australia Pty Ltd

1987-11-11 Publication of NO874704L publication Critical patent/NO874704L/no

1987-11-11 Publication of NO874704D0 publication Critical patent/NO874704D0/no

1995-06-22 Priority to NO952506A priority Critical patent/NO952506L/no

1996-01-02 Publication of NO178504B publication Critical patent/NO178504B/no

1996-04-10 Publication of NO178504C publication Critical patent/NO178504C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
- C07K14/8132—Plasminogen activator inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/972—Plasminogen activators
- G01N2333/9723—Urokinase

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Urology & Nephrology (AREA)
Immunology (AREA)
Physics & Mathematics (AREA)
Microbiology (AREA)
Biophysics (AREA)
Veterinary Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Food Science & Technology (AREA)
Pharmacology & Pharmacy (AREA)
Analytical Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Gastroenterology & Hepatology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Cell Biology (AREA)
General Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Plant Pathology (AREA)
Peptides Or Proteins (AREA)

NO874704A 1986-03-13 1987-11-11 Fr.måte for fr.stilling av minaktivin,DNA-molekyl,gen,vert,prober,preparat som omfatter prober,reagens for lokalisering og defini. av grenser for tumor i histologiske pröver,samt anvendelse av DNA-molekyl,minaktivin og preparat NO178504C (no)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
NO952506A NO952506L (no)	1986-03-13	1995-06-22	Antistoffpreparater mot homogent minaktivin og anvendelse derav for påvisning av minaktivin i humane kroppsvæsker

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
AUPH501786		1986-03-13
AUPH603386		1986-05-22
AUPH810086		1986-09-18
AUPH910486		1986-11-21
PCT/AU1987/000068 WO1987005628A1 (en)	1986-03-13	1987-03-13	Minactivin produced by recombinant dna technology

Publications (4)

Publication Number	Publication Date
NO874704L NO874704L (no)	1987-11-11
NO874704D0 NO874704D0 (no)	1987-11-11
NO178504B NO178504B (no)	1996-01-02
NO178504C true NO178504C (no)	1996-04-10

Family

ID=27424177

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO874704A NO178504C (no)	1986-03-13	1987-11-11	Fr.måte for fr.stilling av minaktivin,DNA-molekyl,gen,vert,prober,preparat som omfatter prober,reagens for lokalisering og defini. av grenser for tumor i histologiske pröver,samt anvendelse av DNA-molekyl,minaktivin og preparat

Country Status (13)

Country	Link
US (1)	US5426044A (da)
EP (1)	EP0238275B1 (da)
JP (2)	JP2589996B2 (da)
KR (1)	KR960001820B1 (da)
CN (2)	CN1032019C (da)
AT (1)	ATE132192T1 (da)
CA (1)	CA1338381C (da)
DE (1)	DE3751646T2 (da)
DK (2)	DK172400B1 (da)
IL (1)	IL81879A (da)
NO (1)	NO178504C (da)
NZ (1)	NZ219608A (da)
WO (1)	WO1987005628A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4923807A (en) *	1984-05-18	1990-05-08	New England Medical Center Hospitals Inc.	Arg-Serpin human plasminogen activator inhibitor designated PAI-2
ES2104610T3 (es) *	1989-09-05	1997-10-16	Biotech Australia Pty Ltd	Proceso para la preparacion de pai-2.
AU625018B2 (en) *	1989-12-20	1992-06-25	Biotech Australia Pty Limited	Variants of pai-2
GB9026737D0 (en) *	1990-12-08	1991-01-30	Delta Biotechnology Ltd	Cancer treatment
US5994309A (en)	1997-07-25	1999-11-30	Angstrom Pharmaceuticals, Inc.	Anti-invasive and anti-angiogenic compositions and methods
CN102586187A (zh) *	2012-02-23	2012-07-18	深圳市中美康士生物科技有限公司	一种中性粒细胞体外保存方法及培养基

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4923807A (en) *	1984-05-18	1990-05-08	New England Medical Center Hospitals Inc.	Arg-Serpin human plasminogen activator inhibitor designated PAI-2
EP0192671B1 (en) *	1984-08-13	1993-12-29	Biotechnology Australia Pty. Ltd.	Minactivin
CA1331355C (en) *	1986-04-21	1994-08-09	Bioenterprises Pty. Ltd	Immunopotentation

1987
- 1987-03-12 IL IL8187987A patent/IL81879A/en not_active IP Right Cessation
- 1987-03-13 WO PCT/AU1987/000068 patent/WO1987005628A1/en not_active Ceased
- 1987-03-13 AT AT87302200T patent/ATE132192T1/de not_active IP Right Cessation
- 1987-03-13 NZ NZ219608A patent/NZ219608A/en unknown
- 1987-03-13 CA CA000531981A patent/CA1338381C/en not_active Expired - Fee Related
- 1987-03-13 KR KR1019870701038A patent/KR960001820B1/ko not_active Expired - Fee Related
- 1987-03-13 JP JP62501852A patent/JP2589996B2/ja not_active Expired - Fee Related
- 1987-03-13 EP EP87302200A patent/EP0238275B1/en not_active Expired - Lifetime
- 1987-03-13 DE DE3751646T patent/DE3751646T2/de not_active Expired - Fee Related
- 1987-03-13 CN CN87102725A patent/CN1032019C/zh not_active Expired - Fee Related
- 1987-11-11 NO NO874704A patent/NO178504C/no not_active IP Right Cessation
- 1987-11-13 DK DK595187A patent/DK172400B1/da not_active IP Right Cessation
1991
- 1991-04-30 US US07/693,636 patent/US5426044A/en not_active Expired - Lifetime
1994
- 1994-05-21 CN CN94105143A patent/CN1100957A/zh active Pending
1995
- 1995-05-29 JP JP7153825A patent/JP2660681B2/ja not_active Expired - Fee Related
1997
- 1997-03-13 DK DK027097A patent/DK27097A/da not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP0238275A3 (en)	1989-05-10
JP2660681B2 (ja)	1997-10-08
DK595187A (da)	1988-07-21
JPH08112094A (ja)	1996-05-07
NO178504B (no)	1996-01-02
ATE132192T1 (de)	1996-01-15
DK595187D0 (da)	1987-11-13
CN1032019C (zh)	1996-06-12
NZ219608A (en)	1991-05-28
KR880701073A (ko)	1988-07-25
WO1987005628A1 (en)	1987-09-24
CA1338381C (en)	1996-06-11
IL81879A (en)	1994-07-31
JP2589996B2 (ja)	1997-03-12
JPS63503354A (ja)	1988-12-08
CN87102725A (zh)	1987-11-11
EP0238275A2 (en)	1987-09-23
DK172400B1 (da)	1998-05-18
EP0238275B1 (en)	1995-12-27
US5426044A (en)	1995-06-20
DK27097A (da)	1997-03-13
NO874704L (no)	1987-11-11
CN1100957A (zh)	1995-04-05
NO874704D0 (no)	1987-11-11
KR960001820B1 (ko)	1996-02-05
DE3751646T2 (de)	1996-10-17
DE3751646D1 (de)	1996-02-08

Similar Documents

Publication	Publication Date	Title
Moses et al.	1980	Purification and characterization of multiplication‐stimulating activity: insulin‐like growth factors purified from rat‐liver‐cell‐conditioned medium
Rinderknecht et al.	1976	Amino-terminal sequences of two polypeptides from human serum with nonsuppressible insulin-like and cell-growth-promoting activities: evidence for structural homology with insulin B chain.
Gimenez-Gallego et al.	1985	Brain-derived acidic fibroblast growth factor: complete amino acid sequence and homologies
ATE319091T1 (de)	2006-03-15	Diagnose von einheimischer sprue/zöliakie mit hilfe von gliadinepitopen
DE68929043D1 (de)	1999-09-09	Für androgen-rezeptor-protein kodierende dna
IT1153265B (it)	1987-01-14	Polipeptidi contenenti la sequenza degli amminoacidi dell'interferone umano immune (interferone umano gamma), relativi veicoli di espressione, loro procedimento di preparazione, composizioni farmaceutiche contenenti tali polipeptidi
ATE90944T1 (de)	1993-07-15	Fuer ein hirudinaehnliches protein kodierende dns- sequenz und verfahren zur herstellung eines solchen proteins.
FI880017A0 (fi)	1988-01-05	Menetelmä haiman erittämän trypsiini-inhibiittorivarianttien valmistamiseksi ja menetelmässä käytettävä DNA, vektori ja isäntäsolu
ATE91722T1 (de)	1993-08-15	Pferde-gamma-interferon.
DK491487D0 (da)	1987-09-18	Dna-sekvens til ekspressionering af biologisk aktivt faktor xiii og anvendelse af samme
JPS6420095A (en)	1989-01-24	Polypeptide having anti-blood coagulating action
NO178504C (no)	1996-04-10	Fr.måte for fr.stilling av minaktivin,DNA-molekyl,gen,vert,prober,preparat som omfatter prober,reagens for lokalisering og defini. av grenser for tumor i histologiske pröver,samt anvendelse av DNA-molekyl,minaktivin og preparat
Wallace et al.	1990	Placement of small lipovitellin subunits within the vitellogenin precursor in Xenopus laevis
BR9714133A (pt)	2000-02-29	ácido nucleico isolado, molécula do mesmo, sonda, vetor de expressão recombinante, célula, polipeptìdeo, proteìna de fusão formulação de vacina e processos para produzir um polipeptìdeo de h. pylori, para detctar a presença de um ácido nucleico de helicobacter em uma amostra, para tratar ou reduzir um risco de infecção por h. pylori em um indivìduo e para produzir uma formulação de vacina
DE69233245D1 (de)	2003-12-11	Verfahren zur Herstellung von Peptiden
Murano et al.	1977	Primary structure of the amino terminal regions of chicken fibrin chains
Francis et al.	1988	Carboxyl-terminal amino acid sequences of two variant forms of the gamma chain of human plasma fibrinogen.
Goodman et al.	1970	Pyrrolidonecarboxylic acid at the N-terminal positions of polypeptide chains from leopard shark immunoglobulins
WO2001036476A3 (en)	2001-11-22	Ing2, an iaps associated cell cycle protein, compositions and methods of use
KR100988706B1 (ko)	2010-10-18	재조합 에리트로포이에틴의 신규한 정제방법
Gooderham	1980	Structural studies on the high mobility group non-histone chromosomal proteins q and 2 from calf thymus
MARDER	1988	Carboxyl-terminal amino acid sequences of two variant forms of the y chain of human plasma fibrinogen

Legal Events

Date	Code	Title	Description
2002-11-04	MM1K	Lapsed by not paying the annual fees	Free format text: LAPSED IN SEPTEMBER 2002